EGFR and cancer: The Multinational Association of Supportive Care in Cancer (MASCC) Skin Toxicity Study Group has proposed a more comprehensive grading scale specific to the dermatologic adverse events associated with EGFR inhibitors (Lacouture et al., 2010a).